To further investigate whether TRAIL directly inhibits MOG35–55-responsive T cell activation and suppresses the development of autoimmune disease, we first examined the effects of TRAIL on MOG35–55-activated T cell proliferation and cytokine production. This evidence concerns the gene TNFSF10 and autoimmune disease.